antineoplaston a10 Report issue

Small molecule Experimental
AACT DrugBank PubChem

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: O=C1CC[C@H](NC(=O)Cc2ccccc2)C(=O)N1
  • InChIKey: OQGRFQCUGLKSAV-JTQLQIEISA-N
  • Mol. Mass: 246.27
  • ALogP: 0.15
  • ChEMBL Molecule:
    antineoplaston a10  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Alternative names

antineoplaston a10 | antineoplaston a 10

Organizations (1)

Research & Development (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (39)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (39)


 

Adenocarcinoma (Phase 2)

Adrenocortical Carcinoma (Phase 2)

Astrocytoma (Phase 2)

Breast Neoplasms (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Islet Cell (Phase 2)

Carcinoma, Merkel Cell (Phase 2)

Carcinoma, Neuroendocrine (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Colonic Neoplasms (Phase 2)

Esophageal Neoplasms (Phase 2)

Glioblastoma (Phase 2)

Glioma (Phase 2)

Head and Neck Neoplasms (Phase 2)

Intestinal Neoplasms (Phase 2)

Kidney Neoplasms (Phase 2)

Liver Neoplasms (Phase 2)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Lymphoma, Mantle-Cell (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Melanoma (Phase 2)

Mesothelioma, Malignant (Phase 2)

Multiple Myeloma (Phase 2)

Neoplasms (Phase 2)

Neuroblastoma (Phase 2)

Neuroectodermal Tumors, Primitive (Phase 2)

Oligodendroglioma (Phase 2)

Ovarian Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 2)

Pituitary Neoplasms (Phase 2)

Prostatic Neoplasms (Phase 2)

Sarcoma (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Stomach Neoplasms (Phase 2)

Urinary Bladder Neoplasms (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Vulvar Neoplasms (Phase 2)

Waldenstrom Macroglobulinemia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 46
  • # of Trial Organizations: 1

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue